Eden Research (LON:EDEN) Trading Down 3.3% – Should You Sell?

Eden Research plc (LON:EDEN) shares traded down 3.3% during mid-day trading on Saturday . The stock traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). 450,985 shares changed hands during trading, a decline of 52% from the average session volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Trading Down 3.3 %

The company has a quick ratio of 2.42, a current ratio of 3.80 and a debt-to-equity ratio of 1.26. The firm’s 50 day simple moving average is GBX 3.87 and its 200-day simple moving average is GBX 3.95. The company has a market capitalization of £18.56 million, a PE ratio of -12.19 and a beta of 0.92.

Insiders Place Their Bets

In other news, insider Alexander John Abrey bought 540,540 shares of the firm’s stock in a transaction dated Tuesday, January 28th. The stock was acquired at an average cost of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($27,362.19). Also, insider Lykele van der Broek bought 256,000 shares of the firm’s stock in a transaction dated Thursday, February 6th. The stock was purchased at an average price of GBX 4 ($0.05) per share, with a total value of £10,240 ($12,958.74). 14.02% of the stock is owned by insiders.

About Eden Research

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.